pfizer 3sbio - Search News

News

Pfizer Strikes Deal With China's 3SBio

Investopedia on MSN · 6h

Pfizer Inks Up to $6B Deal to Market 3SBio's Cancer Drug Outside China

Key Takeaways Pfizer said late Monday that it has agreed to a deal to help develop and market a Chinese cancer drug across the globe.Chinese firm 3SBio is developing a drug that is in trials to treat several forms of cancer,

Seeking Alpha · 3h

Pfizer Thinks Bigger With 3SBio Deal

Pfizer Inc. boosts its oncology pipeline with strategic control of PD-1/VEGF bispecific drugs via 3SBio deal. Click for more on the deal and its PFE implications.

Pfizer signs up to $6 billion licensing deal with China's 3SBio for cancer drug

Pfizer has signed a licensing agreement worth up to $6 billion with Chinese pharmaceutical products developer 3SBio Inc for the development, manufacturing and commercialization of a drug undergoing trials for treatment of certain types of cancer and tumours,

Pfizer, 3SBio Forge Licensing Pact for SSGJ-707 to Target Lung, Colorectal, and Gynecologic Cancers

Under terms of the deal, Pfizer will gain rights to develop, manufacture, and commercialize SSGJ-707 outside of China.

5h

Stock Movers: Home Depot, 3SBio-Pfizer, UNH

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Fierce Biotech10h

Pfizer pays 3SBio $1.25B for PD-1xVEGF bispecific, joining red-hot race with BioNTech, Merck

Pfizer has joined the PD-1xVEGF bispecific gold rush. The Big Pharma is paying 3SBio $1.25 billion upfront for ex-China ...

2h

Pfizer Stock Is Trading Higher Tuesday: What's Going On?

Pfizer Inc (NYSE:PFE) shares are moving higher Tuesday following multiple developments. Here's a look at what's going on.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results